Top 10 Companies in the (S)-2-Chlorophenylglycine (CAS 141315-50-6) Market (2026): Market Leaders Powering Global Chiral Chemistry

MARKET INSIGHTS

The Global (S)-2-Chlorophenylglycine (CAS 141315-50-6) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(S)-2-Chlorophenylglycine is a non-proteinogenic, enantiopure amino acid derivative bearing a chlorine substituent at the ortho position of the phenyl ring. Characterized by its high optical purity and well‑defined stereochemistry, this compound serves as a critical chiral building block in the synthesis of pharmaceutically active molecules, particularly in the development of cardiovascular agents, antiplatelet drugs, and CNS‑active compounds. Its relevance in asymmetric synthesis and resolution chemistry has made it a compound of growing interest across fine chemical and API manufacturing sectors.

The market is witnessing steady expansion, driven primarily by increasing demand for enantiomerically pure intermediates in drug development pipelines and the broader growth of the chiral chemicals industry. Furthermore, rising R&D investments in asymmetric synthesis and the growing adoption of single‑enantiomer drugs – which now account for a significant share of new molecular entity approvals globally – continue to underpin demand for compounds such as (S)-2‑Chlorophenylglycine. Key suppliers operating in this space include Alfa Aesar, TCI Chemicals, and Sigma‑Aldrich (Merck KGaA), among other specialty fine chemical manufacturers.

(S)-2-Chorophenylglycine (CAS 141315-50-6) Market – View in Detailed Research Report

---

🔟 1. Alfa Aesar

Headquarters: Houston, Texas, USA
Key Offering: High‑purity chiral amino acids and fine chemicals for pharmaceutical synthesis

Alfa Aesar is a leading supplier of specialty chemicals, providing a broad portfolio of chiral intermediates to the pharmaceutical and fine chemical industries. Their (S)-2‑Chlorophenylglycine is available in pharmaceutical‑grade purity (≥98% ee) and is used extensively in the synthesis of cardiovascular and CNS‑active APIs.

Sustainability & Growth Initiatives:

• Investment in continuous flow synthesis to reduce solvent waste
• Partnerships with academic institutions to develop greener biocatalytic routes
• Commitment to ISO 14001 environmental management systems across manufacturing sites

---

9️⃣ 2. TCI Chemicals

Headquarters: New York, New York, USA
Key Offering: Custom synthesis and supply of chiral building blocks for API development

TCI Chemicals specializes in the provision of high‑quality chiral intermediates, including (S)-2‑Chlorophenylglycine, to pharmaceutical companies worldwide. Their robust GMP facilities ensure consistent quality for large‑scale production.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes
• Development of scalable enzymatic synthesis platforms
• Active participation in the ICH Q7 guidelines for GMP intermediates

---

8️⃣ 3. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: Comprehensive catalog of chiral amino acids for research and industrial use

Sigma‑Aldrich provides (S)-2‑Chlorophenylglycine in research, custom, and pharmaceutical grades, supporting both early‑stage discovery and late‑stage manufacturing.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles in synthesis routes
• Investment in waste‑minimization technologies
• Collaboration with partners to improve supply chain transparency

---

7️⃣ 4. Chemieliva Pharmaceutical Co., Ltd.

Headquarters: Changzhou, China
Key Offering: High‑purity chiral intermediates for pharmaceutical manufacturing

Chemieliva’s manufacturing capabilities focus on scalable asymmetric synthesis, delivering (S)-2‑Chlorophenylglycine with high enantiomeric excess for use in complex API synthesis.

Sustainability & Growth Initiatives:

• Integration of renewable energy sources in production facilities
• Continuous improvement of process efficiency to reduce carbon footprint
• Participation in China’s Green Chemistry Initiative

---

6️⃣ 5. AstaTech, Inc.

Headquarters: Shanghai, China / San Francisco, USA
Key Offering: Custom chiral synthesis services and high‑grade intermediates

AstaTech offers tailored synthesis of (S)-2‑Chlorophenylglycine, supporting contract research organizations and CDMOs with GMP‑compliant products.

Sustainability & Growth Initiatives:

• Development of biocatalytic processes for lower energy consumption
• Use of recyclable solvents in chemical synthesis
• Collaboration with global pharma partners to streamline supply chains

---

5️⃣ 6. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: Advanced halogenated chiral intermediates for specialty chemical applications

Fluorochem’s (S)-2‑Chlorophenylglycine is used in the development of chiral ligands and organocatalysts, expanding its utility beyond pharmaceuticals.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop water recycling systems
• Research into low‑toxicity synthesis routes
• Engagement with the UK’s Green Chemistry Hub

---

4️⃣ 7. Combi‑Blocks, Inc.

Headquarters: San Diego, California, USA
Key Offering: Custom synthesis of chiral building blocks for drug discovery

Combi‑Blocks specializes in delivering (S)-2‑Chlorophenylglycine to early‑stage R&D labs and CROs, ensuring high purity and rapid turnaround.

Sustainability & Growth Initiatives:

• Adoption of micro‑reactor technology for efficient synthesis
• Use of renewable feedstocks in raw material sourcing
• Partnerships with universities for green chemistry research

---

3️⃣ 8. Changzhou Synblock Pharmaceutical & Chemical Technology Co., Ltd.

Headquarters: Changzhou, China
Key Offering: Large‑scale production of chiral amino acids for API manufacturing

Changzhou Synblock provides (S)-2‑Chlorophenylglycine at pharmaceutical grade, supporting high‑volume production of cardiovascular and CNS drugs.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing lines
• Optimization of waste‑to‑energy conversion processes
• Alignment with China’s 14th Five‑Year Plan for chemical industry upgrade

---

2️⃣ 9. Ark Pharm, Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Pharmaceutical‑grade chiral intermediates for drug development

Ark Pharm offers (S)-2‑Chlorophenylglycine with stringent purity specifications, catering to both small‑molecule and biologic drug pipelines.

Sustainability & Growth Initiatives:

• Use of green solvents in synthesis operations
• Investment in process intensification to reduce water usage
• Participation in the US Pharmacopeia’s sustainability initiatives

---

1️⃣ 10. Hangzhou Keying Chem Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: High‑purity chiral building blocks for API and fine chemical synthesis

Hangzhou Keying Chem provides (S)-2‑Chlorophenylglycine with a focus on scalable asymmetric synthesis and stringent quality control.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in production facilities
• Implementation of closed‑loop solvent recovery systems
• Collaboration with Chinese pharmaceutical companies to streamline supply chains

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307802/chorophenylglycine-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307802/chorophenylglycine-market

---

📈 Outlook: Global Growth Trajectory and Market Resilience

The (S)-2‑Chlorophenylglycine market is positioned for robust growth, driven by the continued expansion of the chiral chemicals industry and the increasing adoption of single‑enantiomer drugs. Regulatory emphasis on enantiopurity, coupled with rising R&D investment in asymmetric synthesis, will sustain demand for high‑purity intermediates. Geographic diversification, especially in Asia‑Pacific, will provide a stable supply base, while the United States and Europe will continue to drive premium pricing through stringent quality requirements.

---

🔮 Future Trends: Innovation, Sustainability, and Digitalization

• Advances in biocatalysis and engineered enzymes will lower production costs and enhance scalability.
• Continuous flow chemistry and process intensification will improve yield and reduce environmental impact.
• Digitalization of supply chains and real‑time analytics will increase transparency and quality assurance.
• Integration of green chemistry principles will become a competitive differentiator for manufacturers.